| Bridging Pharma GmbH - Tiamdra 2,5 mg, Tabletten | | 65740 | | 01 | | Tiamdra 2,5 mg | | Tabletten | | G02CB01 | | Bromocriptin | | 06.02.2015 | | |
| | Composition | | bromocriptinum 2.5 mg ut bromocriptini mesilas, silica colloidalis anhydrica, dinatrii edetas corresp. natrium 0.06 mg, magnesii stearas, acidum maleicum, maydis amylum, amylum pregelificatum, lactosum monohydricum 116 mg, pro compresso. | | Packungsbestandteile | | Comprimés | | | | Principe actif | Concentr. |
|---|
| Bromocriptine | 2.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Maleicum | | | Amylum Pregelificatum | | | Dinatrii Edetas | | | Lactose Monohydrate | 116 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | DDP | DDP | B | | Non |
|
|
